Some formulations contain sodium or potassium salts which may contribute to fluid retention in sensitive individuals, particularly those with cardiovascular or kidney conditions
Mnzker J, Haase N, Till A et al
and MIMS-iron, with pro-inflammatory molecular features, including increased expression of MHC class II, ferritin complex, FcY receptor for immunoglobulin, and complement C1 complex (C1QA and C1QB) expressing genes for ribosomal proteins, indicating a role in antigen presentation and perpetuation of inflammation (108)
This section covers what to expect after your first month, during dose escalation, at your maintenance dose, and when considering whether to continue or taper your treatment
Ethics approval and consent to participate N/A
J Biol Chem (1990) 265(14):80018